RRC
63
8
SLG
53
-2
ISRG
71
3
AZO
58
-2
FTI
73
4
BK
68
-3
ABT
53
-3
HRL
50
-3
PH
66
2
AVY
51
-2
HBAN
56
2
SO
48
-2
URBN
70
-2
APH
64
3
KLAC
57
3
CNX
76
5
MCO
78
3
AAP
35
-6
ESS
59
2
GOOGL
72
5
RRC
63
8
SLG
53
-2
ISRG
71
3
AZO
58
-2
FTI
73
4
BK
68
-3
ABT
53
-3
HRL
50
-3
PH
66
2
AVY
51
-2
HBAN
56
2
SO
48
-2
URBN
70
-2
APH
64
3
KLAC
57
3
CNX
76
5
MCO
78
3
AAP
35
-6
ESS
59
2
GOOGL
72
5
Financhill
Back

Avidity Biosciences 10K Form

Sell
30

RNA
Avidity Biosciences

Last Price:
33.78
Seasonality Move:
53.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $9.56M
Cash Flow: $-67.32M
Price / Cash Flow: 0
Annual Sales: $12.64
Price / Book: 2.86

Profitability

EPS (TTM): -2.89000
Net Income (TTM): $-280.49M
Gross Margin: $8.9M
Return on Equity: -30.66%
Return on Assets: -27.28%

Avidity Biosciences Earnings Forecast

Key Avidity Biosciences Financial Ratios

  • The Gross Profit Margin over the past 1 years for RNA is 100.00%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 566.84% of Gross Profit Margin.
  • The Research & Development expenses have been 1,997.57% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RNA is -2,219.87% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Avidity Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 17.76
Quick Ratio: 17.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Sell
30
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy or a Sell?